nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Oesophageal stenosis—Riluzole—amyotrophic lateral sclerosis	0.0593	0.061	CcSEcCtD
Esomeprazole—Lansoprazole—MAPT—amyotrophic lateral sclerosis	0.0282	1	CrCbGaD
Esomeprazole—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0237	0.0244	CcSEcCtD
Esomeprazole—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0201	CcSEcCtD
Esomeprazole—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.019	0.0195	CcSEcCtD
Esomeprazole—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0173	CcSEcCtD
Esomeprazole—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0171	CcSEcCtD
Esomeprazole—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0161	CcSEcCtD
Esomeprazole—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0159	CcSEcCtD
Esomeprazole—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0157	CcSEcCtD
Esomeprazole—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0155	CcSEcCtD
Esomeprazole—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0141	CcSEcCtD
Esomeprazole—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0132	CcSEcCtD
Esomeprazole—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0131	CcSEcCtD
Esomeprazole—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0117	CcSEcCtD
Esomeprazole—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0117	CcSEcCtD
Esomeprazole—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0115	CcSEcCtD
Esomeprazole—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0107	CcSEcCtD
Esomeprazole—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0105	CcSEcCtD
Esomeprazole—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0104	CcSEcCtD
Esomeprazole—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0102	CcSEcCtD
Esomeprazole—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00976	0.01	CcSEcCtD
Esomeprazole—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00918	0.00944	CcSEcCtD
Esomeprazole—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00918	0.00944	CcSEcCtD
Esomeprazole—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00918	0.00944	CcSEcCtD
Esomeprazole—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00912	0.00939	CcSEcCtD
Esomeprazole—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00896	0.00922	CcSEcCtD
Esomeprazole—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00876	0.00902	CcSEcCtD
Esomeprazole—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00871	0.00897	CcSEcCtD
Esomeprazole—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0083	0.00854	CcSEcCtD
Esomeprazole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00804	0.00828	CcSEcCtD
Esomeprazole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00803	CcSEcCtD
Esomeprazole—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00803	CcSEcCtD
Esomeprazole—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00766	0.00788	CcSEcCtD
Esomeprazole—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00762	0.00784	CcSEcCtD
Esomeprazole—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00759	0.00781	CcSEcCtD
Esomeprazole—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00745	0.00766	CcSEcCtD
Esomeprazole—Injury—Riluzole—amyotrophic lateral sclerosis	0.00725	0.00746	CcSEcCtD
Esomeprazole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0073	CcSEcCtD
Esomeprazole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.007	0.0072	CcSEcCtD
Esomeprazole—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00691	0.00711	CcSEcCtD
Esomeprazole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00685	0.00705	CcSEcCtD
Esomeprazole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00688	CcSEcCtD
Esomeprazole—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00685	CcSEcCtD
Esomeprazole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00685	CcSEcCtD
Esomeprazole—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00685	CcSEcCtD
Esomeprazole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00675	CcSEcCtD
Esomeprazole—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00662	CcSEcCtD
Esomeprazole—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00624	CcSEcCtD
Esomeprazole—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00619	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.006	0.00617	CcSEcCtD
Esomeprazole—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00607	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00605	CcSEcCtD
Esomeprazole—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00605	CcSEcCtD
Esomeprazole—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0058	0.00596	CcSEcCtD
Esomeprazole—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00592	CcSEcCtD
Esomeprazole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00592	CcSEcCtD
Esomeprazole—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00592	CcSEcCtD
Esomeprazole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00581	CcSEcCtD
Esomeprazole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00561	0.00577	CcSEcCtD
Esomeprazole—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00563	CcSEcCtD
Esomeprazole—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00554	CcSEcCtD
Esomeprazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00554	CcSEcCtD
Esomeprazole—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00547	CcSEcCtD
Esomeprazole—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00546	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00541	CcSEcCtD
Esomeprazole—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00539	CcSEcCtD
Esomeprazole—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00521	0.00536	CcSEcCtD
Esomeprazole—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00528	CcSEcCtD
Esomeprazole—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00528	CcSEcCtD
Esomeprazole—Depression—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00527	CcSEcCtD
Esomeprazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.005	0.00515	CcSEcCtD
Esomeprazole—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.005	0.00515	CcSEcCtD
Esomeprazole—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00513	CcSEcCtD
Esomeprazole—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00504	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00485	0.005	CcSEcCtD
Esomeprazole—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00498	CcSEcCtD
Esomeprazole—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00496	CcSEcCtD
Esomeprazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00493	CcSEcCtD
Esomeprazole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00483	CcSEcCtD
Esomeprazole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00475	CcSEcCtD
Esomeprazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00474	CcSEcCtD
Esomeprazole—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00472	CcSEcCtD
Esomeprazole—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00472	CcSEcCtD
Esomeprazole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00471	CcSEcCtD
Esomeprazole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00468	CcSEcCtD
Esomeprazole—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00467	CcSEcCtD
Esomeprazole—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00466	CcSEcCtD
Esomeprazole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00452	0.00465	CcSEcCtD
Esomeprazole—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00448	CcSEcCtD
Esomeprazole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00443	CcSEcCtD
Esomeprazole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00428	CcSEcCtD
Esomeprazole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00427	CcSEcCtD
Esomeprazole—Chills—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00426	CcSEcCtD
Esomeprazole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00419	CcSEcCtD
Esomeprazole—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00415	CcSEcCtD
Esomeprazole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00413	CcSEcCtD
Esomeprazole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00407	CcSEcCtD
Esomeprazole—Tension—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00405	CcSEcCtD
Esomeprazole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00404	CcSEcCtD
Esomeprazole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00401	CcSEcCtD
Esomeprazole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00399	CcSEcCtD
Esomeprazole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00386	0.00397	CcSEcCtD
Esomeprazole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00387	CcSEcCtD
Esomeprazole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00383	CcSEcCtD
Esomeprazole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00382	CcSEcCtD
Esomeprazole—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00379	CcSEcCtD
Esomeprazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00377	CcSEcCtD
Esomeprazole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00372	CcSEcCtD
Esomeprazole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00371	CcSEcCtD
Esomeprazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0037	CcSEcCtD
Esomeprazole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00365	CcSEcCtD
Esomeprazole—Cough—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0036	CcSEcCtD
Esomeprazole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00356	CcSEcCtD
Esomeprazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00351	CcSEcCtD
Esomeprazole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00351	CcSEcCtD
Esomeprazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00351	CcSEcCtD
Esomeprazole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0035	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00349	CcSEcCtD
Esomeprazole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00347	CcSEcCtD
Esomeprazole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00344	CcSEcCtD
Esomeprazole—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0033	0.0034	CcSEcCtD
Esomeprazole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00337	CcSEcCtD
Esomeprazole—Infection—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00335	CcSEcCtD
Esomeprazole—Shock—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00331	CcSEcCtD
Esomeprazole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0033	CcSEcCtD
Esomeprazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0033	CcSEcCtD
Esomeprazole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00329	CcSEcCtD
Esomeprazole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00327	CcSEcCtD
Esomeprazole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00326	CcSEcCtD
Esomeprazole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00321	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00307	CcSEcCtD
Esomeprazole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00305	CcSEcCtD
Esomeprazole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00303	CcSEcCtD
Esomeprazole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00292	0.003	CcSEcCtD
Esomeprazole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00291	0.003	CcSEcCtD
Esomeprazole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00297	CcSEcCtD
Esomeprazole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00293	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00291	CcSEcCtD
Esomeprazole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00282	0.0029	CcSEcCtD
Esomeprazole—Pain—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00288	CcSEcCtD
Esomeprazole—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00288	CcSEcCtD
Esomeprazole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00278	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00276	CcSEcCtD
Esomeprazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00268	CcSEcCtD
Esomeprazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00266	CcSEcCtD
Esomeprazole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00266	CcSEcCtD
Esomeprazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00248	CcSEcCtD
Esomeprazole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00242	CcSEcCtD
Esomeprazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00238	CcSEcCtD
Esomeprazole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00231	CcSEcCtD
Esomeprazole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00223	CcSEcCtD
Esomeprazole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00214	CcSEcCtD
Esomeprazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00212	CcSEcCtD
Esomeprazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00212	CcSEcCtD
Esomeprazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00211	CcSEcCtD
Esomeprazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00194	0.002	CcSEcCtD
